gastric ulcer
Information
- Disease name
- gastric ulcer
- Disease ID
- DOID:10808
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03553563 | Completed | Phase 3 | A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer | July 24, 2018 | December 27, 2022 |
| NCT01729182 | Completed | Nexium Capsules LDA Specific Clinical Experience Investigation | January 1, 2013 | March 9, 2017 | |
| NCT01762397 | Completed | Phase 1 | A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Oral Administration in Healthy Male Volunteers | December 2012 | |
| NCT01964131 | Completed | Phase 1 | BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects | October 2013 | December 2013 |
| NCT02423187 | Completed | Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin | March 17, 2015 | October 30, 2017 | |
| NCT02759224 | Completed | Phase 1 | A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet | April 15, 2016 | December 29, 2016 |
| NCT02761512 | Completed | Phase 3 | Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer | May 2016 | December 28, 2018 |
| NCT03050307 | Completed | Phase 3 | Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection | April 17, 2017 | May 26, 2020 |
| NCT03060733 | Completed | Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects | February 14, 2017 | May 14, 2018 | |
| NCT03060746 | Completed | Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects | February 14, 2017 | May 3, 2018 | |
| NCT03291418 | Completed | Phase 1/Phase 2 | To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy Subjects | September 8, 2017 | April 30, 2018 |
| NCT00132171 | Completed | Phase 3 | Helicobacter Pylori Eradication With a New Sequential Treatment | January 2001 | December 2001 |
| NCT03609892 | Completed | Phase 4 | Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy | August 1, 2018 | August 20, 2019 |
| NCT04410211 | Completed | N/A | Comparison Between Two Types of Sedation for Elective Upper Endoscopy Procedures | June 1, 2018 | November 30, 2019 |
| NCT04724291 | Completed | N/A | MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients) | February 10, 2021 | June 10, 2023 |
| NCT05518929 | Completed | Phase 4 | Hypoxia During Gastroenterological Endoscope Procedures Sedated With Ciprofol In Overweight Or Obesity Patients | September 8, 2022 | August 30, 2023 |
| NCT06167226 | Completed | Understanding Ayurveda Disease Conditions and Treatment Responses | December 29, 2021 | March 31, 2023 | |
| NCT00153673 | Completed | Phase 3 | Effect of Selective COX-2 Inhibition on Ulcer Healing | February 2001 | April 12, 2017 |
| NCT00173953 | Completed | N/A | Lymphocytic Subsets and Cytokine Production With H. Pylori Infection | January 2001 | October 2001 |
| NCT00197457 | Completed | Phase 2 | Pepsinogens as the Early Marker of H. Pylori Eradication | June 2001 | |
| NCT00401752 | Completed | Phase 3 | Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-induced Gastric Ulcer | March 2006 | November 2008 |
| NCT00428701 | Completed | Phase 4 | An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium | October 2006 | November 2006 |
| NCT00441727 | Completed | Phase 3 | Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA) | February 2007 | August 2008 |
| NCT00527787 | Completed | Phase 3 | Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen | September 2007 | October 2008 |
| NCT00527904 | Completed | Phase 3 | A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO) | March 2007 | March 2009 |
| NCT00542789 | Completed | Phase 3 | Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID | August 2007 | February 2009 |
| NCT00595517 | Completed | Phase 3 | Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer | October 2007 | September 2009 |
| NCT00960869 | Completed | Phase 3 | Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers | October 2009 | February 2012 |
| NCT00961350 | Completed | Phase 3 | A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers | October 2009 | February 2012 |
| NCT01129011 | Completed | Phase 3 | Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) Naproxen | September 2007 | October 2008 |
| NCT01150162 | Completed | Phase 3 | Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluation | October 2010 | August 2012 |
| NCT01190657 | Completed | Phase 4 | Efficacy and Safety of Teprenone in Patients With Acute Gastritis, Acute Gastric Lesion of Chronic Gastritis With Acute Exacerbation or Gastric Ulcer | May 2010 | February 2013 |
| NCT01435525 | Completed | Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation | September 2011 | March 2014 | |
| NCT01452711 | Completed | Phase 3 | Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric Ulcer | November 2011 | December 2012 |
| NCT01562600 | Completed | Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation | April 19, 2012 | August 27, 2015 | |
| NCT01568385 | Completed | Phase 3 | A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy | April 2012 | September 2013 |
| NCT01568398 | Completed | Phase 3 | A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy | May 2012 | August 2013 |
| NCT05448001 | Not yet recruiting | Phase 3 | Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer | August 15, 2022 | December 15, 2023 |
| NCT05656092 | Not yet recruiting | Phase 3 | A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer | January 2023 | December 2023 |
| NCT05526339 | Not yet recruiting | N/A | HFNO Combined With NPA Reduces Hypoxia During Sedated Gastrointestinal Endoscopy In Obese Patients | September 2022 | May 2024 |
| NCT03972956 | Recruiting | Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease | December 23, 2020 | December 23, 2026 | |
| NCT05517408 | Recruiting | N/A | Dose Exploration of Ciprofol for Sedation in Gastrointestinal Endoscopic Diagnosis and Treatment of Obese Patients. | September 19, 2022 | August 13, 2023 |
| NCT05579444 | Terminated | Systems Biology of Gastrointestinal and Related Diseases | November 11, 2022 | November 29, 2023 | |
| NCT00594854 | Terminated | Phase 3 | Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers in High Risk Subjects Compared to Arthrotec | September 2007 | September 2008 |
| NCT00511745 | Terminated | Safety of Rabeprazole in Patients Under Multiple Treatments | November 2002 | ||
| NCT02689583 | Unknown status | N/A | A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection | March 2016 | |
| NCT04885751 | Unknown status | Phase 4 | Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy | June 1, 2021 | January 31, 2022 |
| NCT01037491 | Unknown status | N/A | Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets | October 2009 | December 2010 |
| NCT00197418 | Unknown status | Phase 2/Phase 3 | Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection | August 2003 | |
| NCT01946633 | Unknown status | N/A | Remote-controlled Capsule Endoscopy: a Feasibility Study | October 2013 | |
| NCT00197470 | Unknown status | N/A | Cytokine Gene Polymorphisms in Gastric Diseases | January 2000 | |
| NCT00149084 | Unknown status | Phase 3 | Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori | April 2003 | |
| NCT03057171 | Unknown status | A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA | May 2015 | April 2020 |
- Disase is a (Disease Ontology)
- DOID:750
- Cross Reference ID (Disease Ontology)
- ICD10CM:K25
- Cross Reference ID (Disease Ontology)
- ICD9CM:531
- Cross Reference ID (Disease Ontology)
- MESH:D013276
- Cross Reference ID (Disease Ontology)
- NCI:C3388
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:155681009
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0038358
- Exact Synonym (Disease Ontology)
- acute gastric ulcer with haemorrhage and perforation
- Exact Synonym (Disease Ontology)
- acute gastric ulcer with hemorrhage and obstruction
- Exact Synonym (Disease Ontology)
- acute gastric ulcer with hemorrhage and perforation
- Exact Synonym (Disease Ontology)
- acute gastric ulcer with hemorrhage and perforation, with obstruction
- Exact Synonym (Disease Ontology)
- acute gastric ulcer with hemorrhage and perforation, without mention of obstruction
- Exact Synonym (Disease Ontology)
- acute gastric ulcer with hemorrhage AND with perforation but without obstruction
- Exact Synonym (Disease Ontology)
- acute gastric ulcer with hemorrhage, with obstruction
- Exact Synonym (Disease Ontology)
- acute gastric ulcer with hemorrhage, with perforation AND with obstruction
- Exact Synonym (Disease Ontology)
- acute gastric ulcer with perforation
- Exact Synonym (Disease Ontology)
- acute gastric ulcer with perforation AND obstruction
- Exact Synonym (Disease Ontology)
- acute gastric ulcer with perforation, with obstruction
- Exact Synonym (Disease Ontology)
- acute gastric ulcer without hemorrhage and without perforation
- Exact Synonym (Disease Ontology)
- acute gastric ulcer without hemorrhage, without perforation AND without obstruction
- Exact Synonym (Disease Ontology)
- acute gastric ulcer without mention of hemorrhage or perforation, without mention of obstruction
- Exact Synonym (Disease Ontology)
- bleeding acute gastric ulcer
- Exact Synonym (Disease Ontology)
- chronic gastric ulcer without hemorrhage AND without perforation
- Exact Synonym (Disease Ontology)
- chronic gastric ulcer without hemorrhage AND without perforation but with obstruction
- Exact Synonym (Disease Ontology)
- chronic gastric ulcer without mention of hemorrhage or perforation, with obstruction
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002592
- ICD10 preferred id (Insert disease from ICD10)
- D0008639
- ICD10 class code (Insert disease from ICD10)
- K25